Amplifications of a region of chromosome 2p13 have been observed in various B-cell malignancies. After having ruled out several candidate genes, British, German and US researchers were able to identify the BCL11A gene and its 3 major RNA isoforms as the pathologic target for the amplification (Blood. 2001 Dec 1; 98(12):3413-3420). The researchers also reported that a previously identified translocation may contribute to deregulation of the BCL11A locus.
P. W. Tucker
University of Texas at Austin, ESB 534, 100W 24th St,
Austin, TX 78705
Martin J. S. Dyer
Department of Haematology, University of Leicester
PO Box 65, Leicester, LE2 7LX, UK
Message posted by: Ulrike Sattler
Bookmark and Share this page (what is this?)
Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.
Use the links below to share this article on the social bookmarking site of your choice.
Read more about social bookmarking at Wikipedia - Social Bookmarking
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...